Volpara Health Technologies (ASX: VHT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Volpara Health Technologies Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Volpara Health Technologies (ASX: VHT)
Latest News
Share Market News
Here's why analysts are bullish on this ASX tech stock
Share Market News
ALL ORDINARIES finishes lower Tuesday: 8 ASX shares you missed
Share Market News
Volpara share price on watch after strong third quarter update
Speculative
4 small cap ASX shares that could be stars of the future
Speculative
4 exciting ASX small cap shares with explosive growth potential
Healthcare Shares
Is the Volpara Health share price a buy?
Speculative
3 quality ASX tech shares for small cap investors to buy
Speculative
10 exciting small cap ASX shares to watch in 2020
Share Market News
Is Pro Medicus eyeing a takeover of Volpara Healthcare?
Speculative
3 fast-growing small cap ASX shares to watch
Speculative
10 exciting small cap ASX shares to watch in 2020
Speculative
5 exciting small cap ASX shares to watch in 2020
Frequently Asked Questions
-
No, the ASX healthcare share has not yet paid any dividends.
-
Volpara listed on 27 April 2016.
VHT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Volpara Health Technologies
Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.
Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.
Volpara Health Technologies Ltd (ASX: VHT) was removed from the ASX Official List on 22 May 2024.
